Genvor Incorporated (OTC:GNVR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Donald A Kalkofen Other companies: Protagonist Therapeutics, Inc. (Chief Financial Officer · May 28, 2019 – Feb 15, 2022 · Past) | Chief Financial Officer · Since at least May 18, 2026 |
| Brianna Fochs | Senior Scientist & Lab Manager · Since at least Nov 4, 2026 |
| Carly Scaduto | Director, Corporate Communications · Since at least Jul 27, 2026 |
| Chad Lee Pawlak Sr | Chief Executive Officer, Director · Since at least Jan 17, 2024 |
| Chad Pawlak | Chief Executive Officer · Since at least Apr 16, 2026 |
| Clayton Yates | Co-Founder · Since at least Aug 25, 2023 |
| Don Kalkofen | Chief Financial Officer · Since at least Nov 4, 2026 |
| Genvor Incorporated | Investor Relations · Since at least Apr 17, 2026 |
| George Stavrides | Executive Vice President, Business Development & Commercialization – Agriculture · Since at least Jul 27, 2026 |
| Jessee M Jaynes | Chief Research Officer, Director · Since at least May 8, 2025 |
| Jesse Jaynes | Co-Founder · Since at least Jul 27, 2026 |
| John M. Viglotti | SVP Corporate Services · Since at least Dec 4, 2025 |
| Judith Selene Miller | Chief Business Officer, Director · Aug 25, 2023 – Mar 15, 2024 · Past |
| Lance Culnane | Director, AI & Machine Learning · Since at least Nov 4, 2026 |